Arsena, Hermis, and Sri Melati Munir. “Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials”. Bioscientia Medicina : Journal of Biomedicine and Translational Research, vol. 10, no. 7, June 2026, pp. 2624-36, https://doi.org/10.37275/bsm.v10i7.1638.